ALLMedicine™ Bleeding Time Center

Nov 29th, 2021 - Thrombocytopenia is one of the most common hematological disease that can be life-threatening caused by bleeding complications. However, the treatment options for thrombocytopenia remain limited. In this study, giemsa staining, phalloidin staining...

Nov 16th, 2021 - Vascular injury initiates rapid platelet activation which is critical for hemostasis, while it also cause fatal thrombotic diseases, such as myocardial infarction or ischemic stroke. To study the inhibitory effects and underlying mechanisms of XJ-...

Nov 16th, 2021 - Practice Essentials Acquired hemophilia is a rare but potentially life-threatening bleeding disorder caused by the development of autoantibodies (inhibitors) directed against plasma coagulation factors, most frequently factor VIII (FVIII).1 Acquir...

Nov 11th, 2021 - The investigators will enroll patients with coronary disease >1 year after an acute coronary syndrome. Subjects will be randomized to one of two treatment plans. One plan the participant will take ticagrelor for one week, then take two weeks off w...

Nov 10th, 2021 - Milvexian (BMS-986177/JNJ-70033093) is an orally bioavailable factor XIa (FXIa) inhibitor currently in phase 2 clinical trials. To evaluate in vitro properties and in vivo characteristics of milvexian. In vitro properties of milvexian were evaluat...

Sep 11th, 2009 - SYNOPSIS OF RECOMMENDATIONS: The Italian Society for Thrombosis and Haemostasis (SISET: Società Italiana per lo Studio dell' Emostasi e della Trombosi) promoted the development of a series of guidelines which would adopt evidence-based medicine me...

Nov 11th, 2021 - The investigators will enroll patients with coronary disease >1 year after an acute coronary syndrome. Subjects will be randomized to one of two treatment plans. One plan the participant will take ticagrelor for one week, then take two weeks off w...

Jan 27th, 2021 - PURPOSE: To determine whether low level laser light therapy is effective as an adjunctive therapy on countering hypercoagulable state parameters (fibrinogen, bleeding time, Prothrombin time) and total cholesterol (, d-dimer and c-reactive protein)...

Jul 24th, 2020 - Historically, orthotopic liver transplantation (OLT) has been associated with major blood loss and the need for massive blood product transfusion . The cause of bleeding during OLT is multifactorial . The extensive surgical trauma plays a major ro...

Feb 21st, 2020 - Participants who had ongoing epistaxis and met the inclusion criteria where enrolled in the pilot study . Bleeding severity was not recorded. All participants enrolled were clinically stable with active epistaxis. Participants who were unstable or...

Sep 24th, 2018 - Preoperative assessment: The day prior to surgery, all patients will undergo pre-anesthetic checkup including detailed history, physical, systemic examination and weight of the patient. All patients will be investigated for exclusion of any of the...

Apr 18th, 2019 - A new approach to inhibiting platelets that may separate the antithrombotic effect from the bleeding risk has shown promising preliminary results, raising the hope of developing an agent for the treatment of acute ischemic stroke that can inhibit ...

Apr 18th, 2019 - A new approach to inhibiting platelets that may separate the antithrombotic effect from the bleeding risk has shown promising preliminary results, raising the hope of developing an agent for the treatment of acute ischemic stroke that can inhibit ...

Dec 11th, 2017 - Hello and welcome. I am Dr George Lundberg, and this is At Large at Medscape. Most lab tests that are ordered do not need to be done. The results are either normal, negative, or show no change from the previous test. Why do them? I admit that ther...

Oct 12th, 2016 - High doses of garlic may prolong bleeding time; therefore, it should be discontinued 7-10 days before surgery. Some evidence has suggested garlic may have antihypertensive effects. Other studies have shown that an increase in dietary garlic consum...

Aug 24th, 2016 - Nanoparticles (green) help form clots in injured liver Image courtesy of Erin Lavik PHILADELPHIA—Researchers say they have developed nanoparticles that can congregate at sites of injury and speed blood clotting in vitro and in vivo. The nanopartic.